ClinicalTrials.Veeva

Menu

Defocus (DIMS) Spectacles Versus Ortho-K Lenses (OKL) for Slowing Myopia Progression in Children Aged 6-12 Years. (NISDO)

V

Vejle Hospital

Status

Completed

Conditions

Myopia

Treatments

Device: Defocus Incorporated Multiple Segment (DIMS) Spectacles
Device: Orthokerathology lenses (OKL)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this non-inferiority randomized clinical trial is to compare the myopia control efficacy of Ortho-K lenses (OKL) and Defocus (DIMS) spectacles in myopic children aged 6-12 years. The main question it aims to answer is:

- Is the DIMS spectacle lens not worse than the OKL after 18 months of therapy?

The participants are randomly assigned to either OKL or DIMS spectacles and followed during 18 months of therapy.

Enrollment

90 patients

Sex

All

Ages

6 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

- Myopic children aged 6 to 12 years: Myopia of the 6 to 8-year-olds (inclusive): -1.00 to -4.75 D spherical component and up to -2.50 D of regular astigmatism (both eyes).

Myopia of the 9 to 12-year-olds (inclusive): -2.00 to -4.75 D spherical component and up to -2.50 D of regular astigmatism (both eyes).

  • Anisometropia ≤ 1.50 D cycloplegic spherical equivalent refractive error.
  • Best corrected visual acuity at age 6 to 12 years (inclusive): 0.8 Snellen (equivalent to ≥ 3/5 letter on the 0.8 line = 78 ETDRS letters)

Exclusion criteria

  • Manifest or intermittent squint.
  • Contraindications to the use of OKL comprising (not exhaustive): keratoconus, chronic allergic conjunctivitis and keratoconjunctivitis sicca.
  • Previous eye surgery.
  • Chronic eye disease demanding daily use of eye drops.
  • Non-compliance to eye examinations (unstable fixation or anxiety towards contact lenses).
  • Previous myopia control treatment.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

90 participants in 2 patient groups

OKL
Active Comparator group
Treatment:
Device: Orthokerathology lenses (OKL)
DIMS
Experimental group
Treatment:
Device: Defocus Incorporated Multiple Segment (DIMS) Spectacles

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Lou-Ann Andersen

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems